Ligustrazine Phosphate and Glucose Injection
Function and Efficacy
This product has the effect of resisting platelet aggregation and disaggregating aggregated platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thus producing the effects of anti-thrombosis and thrombolysis.
Ingredients
Ligustrazine phosphate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LigustrazinePhosphateIngredients |
This product has the effect of resisting platelet aggregation and disaggregating aggregated platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thus producing the effects of anti-thrombosis and thrombolysis. More |
848645-86-3 | 6 |
Appearance
This product is a colorless clear liquid.
Indication
Used for ischemic cerebrovascular diseases, such as cerebral ischemia, cerebral thrombosis, and cerebral infarction.
Usage and Dosage
Intravenous drip, 100ml (i.e. 1 bottle) at a time, drip slowly, it should be completed in 3-4 hours, once a day, 10-15 days as a course of treatment or follow the doctor's advice.
Adverse Reactions
Stomach discomfort, dry mouth, and drowsiness may occur occasionally, which can be relieved by reducing the dosage. Allergic reactions may occur occasionally.
Precautions
1. Patients with a history of allergy to any ingredient in this product are prohibited from using this product. 2. Patients with cerebral hemorrhage or bleeding tendency are prohibited from using this product.
Drug Interactions
This product is highly acidic and should not be used in combination with alkaline drugs.
Storage
Keep tightly closed.
Packaging Specification
100ml: 0.1g ligustrazine phosphate and 5g glucose
Manufacturer
Livzon Pharmaceutical Grouping Limin Pharmaceutical FACTORY
-
Founded in:
1997-05-24 -
Address:
No. 89, Gongye West Road, Shaoguan City, Guangdong -
Tax NO.:
91440200618357941C -
Registered Funds:
61.56101 million yuan -
Email: